Impact of flu vaccine on survival after immunotherapy for metastatic castration resistant prostate cancer (mCRPC): Analysis of Medicare claims data

MLA

Rana R. McKay, et al. “Impact of Flu Vaccine on Survival after Immunotherapy for Metastatic Castration Resistant Prostate Cancer (MCRPC): Analysis of Medicare Claims Data.” Journal of Clinical Oncology, vol. 38, May 2020, p. e17591. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........02011a4a0076946fb4e1104b950a519a&authtype=sso&custid=ns315887.

APA

Rana R. McKay, Scott C. Flanders, Jason Hafron, Kate Fitch, Nicholas J. Vogelzang, & Russell K. Pachynski. (2020). Impact of flu vaccine on survival after immunotherapy for metastatic castration resistant prostate cancer (mCRPC): Analysis of Medicare claims data. Journal of Clinical Oncology, 38, e17591.

Chicago

Rana R. McKay, Scott C. Flanders, Jason Hafron, Kate Fitch, Nicholas J. Vogelzang, and Russell K. Pachynski. 2020. “Impact of Flu Vaccine on Survival after Immunotherapy for Metastatic Castration Resistant Prostate Cancer (MCRPC): Analysis of Medicare Claims Data.” Journal of Clinical Oncology 38 (May): e17591. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........02011a4a0076946fb4e1104b950a519a&authtype=sso&custid=ns315887.